BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Jan 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-01-03

Reporting Person: Cooper Jeffrey H (SVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-03	Common Stock	M	2500	$14.39	Disposed	42604	Direct
2012-01-03	Common Stock	S	2500	$34.7520	Disposed	40104	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-03	Stock Option (right to buy)	$14.39	M	2500	Disposed	2019-05-11	Common Stock (2500)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 7, 2011.

F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.47 to $35.18. The reporting person will provide to the issuer, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.